Business - Briefly   

Cheaper diabetes test

MUMBAI, MARCH 2. Aventis Pharma has announced a joint initiative with SRL Ranbaxy to create awareness among diabetes patients about the importance of monitoring blood glucose levels particularly glycosylated hemoglobin or HbA1C (A1C). A1C is accepted worldwide as the `gold standard' of determining long-term blood glucose control in diabetes patients. As a part of this initiative, diabetes patients can avail themselves of the A1C test at a subsidised cost of Rs. 240 (normal cost Rs. 500) against coupons issued by Aventis and SRL Ranbaxy. The coupons will be made available to patients through leading diabetologists and endocrinologists. Samples can be submitted at any of the 250 SRL Ranbaxy diagnostic centres across India.

Our Staff Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

• Efforts to improve trade with Pakistan
• Govt. sets IBP price at Rs. 620
• Tata Indigo Advent unveiled at Geneva auto show
• Tapping the global e-mandi
• SEBI nod for ONGC PNs
• UPL buys registration of two products
• India at Asian Aerospace
• WAPCOS to prepare DPR for Bhutan hydel project
• Hyundai sales up
• Yahoo to add more content to search results
• WTO and U.S. leadership role
• P&G cuts Ariel, Tide prices
• Cheaper diabetes test
• Shourie, Ambani to get honorary doctorate
• Gets additional charge
• Software for power utilities
• A Ford show in Chennai
• Zak plans expo centre
• Broadest tyre from MRF
• Via Tech bags LIC order

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu